Skip to content
★ Sign in to follow
TE

Tom Englund

Executive
Chairman & CEO
Surgical Science Sweden AB
Insider activity · 24 months4 buys0 salesCumulative net flow
Total declarations
7
Company
1
▲ Purchases (5 ops.)
€331k
▼ Sales (0 ops.)
—

Latest filing published 23 Jun 2026 for Surgical Science Sweden AB, €37k.

Filing timeline

BuySale
Tom Englund

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Tom Englund: trading record in brief

This profile gathers the share dealings of Tom Englund in Surgical Science Sweden AB, where the filings describe the role as chief executive. In total, 7 filings cover trades dated from 19 November 2024 to 22 June 2026.

On the market, this insider has only ever bought: 5 purchases, €331k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.

Half of the purchases are above €64k and half below. On 1 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 23 June 2026: a share grant of €37k, in Surgical Science Sweden AB. The latest purchase dates back some time: it was published 342 days ago, on 1 December 2025. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Tom Englund

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◆
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    413,500 SEK0FI-SE
    50,000 shares@ SEK 8.2737.0% of flowTeckningsoptionFI:csv-6c9abbd9b175e34d3895
  • ▲
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    698,000 SEK40FI-SE
    20,000 shares@ SEK 34.900.035% mcap63.0% of flowAktieISIN SE0014428512FI:A003U283-1
    Canonical exit: 1 Mar 2026 (T+90)
  • ◆
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    728,400 SEK0FI-SE
    20,000 shares@ SEK 36.42100.0% of flowTeckningsoptionFI:A003Q223-1
  • ▲
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    416,556 SEK23FI-SE
    2,700 shares@ SEK 154.2811.5% of flowAktieISIN SE0014428512FI:csv-b608d1916c7f5b227142
    Canonical exit: 10 Sept 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    586,000 SEK24FI-SE
    4,000 shares@ SEK 146.5016.3% of flowAktieISIN SE0014428512FI:csv-fc866430118cc736ae46
    Canonical exit: 17 Aug 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    974,015 SEK25FI-SE
    8,500 shares@ SEK 114.5926.6% of flowAktieISIN SE0014428512FI:csv-bb87ea1ce206d9c4303c
    Canonical exit: 10 Jul 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesSurgical Science Sweden AB
    1M SEK25FI-SE
    7,000 shares@ SEK 144.6034.4% of flowAktieISIN SE0014428512FI:csv-24cb99ee31ee2c4be4ce
    Canonical exit: 17 Feb 2025 (T+90)

7 of 7 declarations